“Best of both modalities” approach combines the efficacy, safety and scalability of RNA therapeutics with the multi-year durability of gene therapies Portfolio prioritizes rare, severe, lifelong ...
VANCOUVER, BC, Oct. 9, 2024 /PRNewswire/ - RESAAS Services Inc. (RSS:CA) ("RESAAS") (TSXV: RSS) (OTCQB: RSASF), a leading provider of technology solutions for the real estate industry, today announced ...